These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 31069270)
1. Co-expression of Cas9 and single-guided RNAs in Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y Commun Biol; 2019; 2():161. PubMed ID: 31069270 [TBL] [Abstract][Full Text] [Related]
2. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a. Shin HR; Kweon J; Kim Y Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383 [TBL] [Abstract][Full Text] [Related]
3. A Survey of Genome Editing Activity for 16 Cas12a Orthologs. Zetsche B; Abudayyeh OO; Gootenberg JS; Scott DA; Zhang F Keio J Med; 2020 Sep; 69(3):59-65. PubMed ID: 31723075 [TBL] [Abstract][Full Text] [Related]
4. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a. Swartjes T; Staals RHJ; van der Oost J Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209 [TBL] [Abstract][Full Text] [Related]
5. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759 [TBL] [Abstract][Full Text] [Related]
6. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems. Zhang Y; Ren Q; Tang X; Liu S; Malzahn AA; Zhou J; Wang J; Yin D; Pan C; Yuan M; Huang L; Yang H; Zhao Y; Fang Q; Zheng X; Tian L; Cheng Y; Le Y; McCoy B; Franklin L; Selengut JD; Mount SM; Que Q; Zhang Y; Qi Y Nat Commun; 2021 Mar; 12(1):1944. PubMed ID: 33782402 [TBL] [Abstract][Full Text] [Related]
7. Multiplexed conditional genome editing with Cas12a in Port F; Starostecka M; Boutros M Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22890-22899. PubMed ID: 32843348 [TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9. Yan F; Wang W; Zhang J Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291 [No Abstract] [Full Text] [Related]
9. Genome editing via delivery of Cas9 ribonucleoprotein. DeWitt MA; Corn JE; Carroll D Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976 [TBL] [Abstract][Full Text] [Related]
10. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation. Berkhout B; Gao Z; Herrera-Carrillo E Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922 [TBL] [Abstract][Full Text] [Related]
11. Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes. Meccariello A; Monti SM; Romanelli A; Colonna R; Primo P; Inghilterra MG; Del Corsano G; Ramaglia A; Iazzetti G; Chiarore A; Patti F; Heinze SD; Salvemini M; Lindsay H; Chiavacci E; Burger A; Robinson MD; Mosimann C; Bopp D; Saccone G Sci Rep; 2017 Aug; 7(1):10061. PubMed ID: 28855635 [TBL] [Abstract][Full Text] [Related]
13. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a. Swarts DC; van der Oost J; Jinek M Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230 [TBL] [Abstract][Full Text] [Related]
14. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9. Yang H; Patel DJ Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637 [TBL] [Abstract][Full Text] [Related]
15. [CRISPR/CAS9, the King of Genome Editing Tools]. Bannikov AV; Lavrov AV Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076 [TBL] [Abstract][Full Text] [Related]
16. Efficient Editing of the Nuclear Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076 [TBL] [Abstract][Full Text] [Related]
17. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein. Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898 [TBL] [Abstract][Full Text] [Related]
18. Live-cell imaging reveals the trade-off between target search flexibility and efficiency for Cas9 and Cas12a. Olivi L; Bagchus C; Pool V; Bekkering E; Speckner K; Offerhaus H; Wu WY; Depken M; Martens KJA; Staals RHJ; Hohlbein J Nucleic Acids Res; 2024 May; 52(9):5241-5256. PubMed ID: 38647045 [TBL] [Abstract][Full Text] [Related]
19. PpCas9 from Pasteurella pneumotropica - a compact Type II-C Cas9 ortholog active in human cells. Fedorova I; Vasileva A; Selkova P; Abramova M; Arseniev A; Pobegalov G; Kazalov M; Musharova O; Goryanin I; Artamonova D; Zyubko T; Shmakov S; Artamonova T; Khodorkovskii M; Severinov K Nucleic Acids Res; 2020 Dec; 48(21):12297-12309. PubMed ID: 33152077 [TBL] [Abstract][Full Text] [Related]
20. The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks. Hajizadeh Dastjerdi A; Newman A; Burgio G BioDrugs; 2019 Oct; 33(5):503-513. PubMed ID: 31385197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]